期刊
ANALYTICA CHIMICA ACTA
卷 996, 期 -, 页码 1-9出版社
ELSEVIER
DOI: 10.1016/j.aca.2017.09.021
关键词
Volatile organic compounds; Exhaled breath; Lung cancer; Early diagnosis; Biomarker
资金
- Natural Sciences and Engineering Research Council (NSERC) of Canada
- Canadian MITACS Accelerate Program
Lung cancer is the most common cause of cancer deaths, its global incidence is rising, and continuing rises are predicted. The potential to diagnose lung cancers based on the determination of volatile organic compounds (VOCs) in human breath has been attracting increasing attention with the development of new techniques and methodologies. However, despite many reports of VOC profiling in lung cancer patients, little is known about how specific biomarkers relate to the biochemical pathways involved in lung cancer development, and there is still no reliable method for diagnosing lung cancer at the early stages. This review summarizes some of the latest methods used for monitoring biomarkers in lung cancer patients, which could be applicable for clinical diagnosis. Techniques for capturing and pre-concentrating biomarkers, and the technologies used for subsequently determining them, are also discussed. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据